Directly Observed Weekly Fluoxetine for Major Depressive Disorder Among Hemodialysis Patients: A Single-Arm Feasibility Trial

RATIONALE & OBJECTIVE: Major depressive disorder (MDD) is common among hemodialysis patients, but treatment can add to their pill burden and may be limited by nonadherence. We sought to investigate the value of directly observed, once-weekly fluoxetine dosing in MDD. STUDY DESIGN: Feasibility tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kauffman, Kelley M., Dolata, Jacqueline, Figueroa, Maria, Gunzler, Douglas, Huml, Anne, Pencak, Julie, Sajatovic, Martha, Sehgal, Ashwini R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978139/
https://www.ncbi.nlm.nih.gov/pubmed/35386606
http://dx.doi.org/10.1016/j.xkme.2022.100413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978139/
https://www.ncbi.nlm.nih.gov/pubmed/35386606
http://dx.doi.org/10.1016/j.xkme.2022.100413

Ejemplares similares